Home
AORT
AORT News

Latest Artivion Inc. (AORT) News on August 6, 2025

The 5 Most Interesting Analyst Questions From Artivion’s Q1 Earnings Call

StockStory

a month ago

The 5 Most Interesting Analyst Questions From Artivion’s Q1 Earnings Call

Argus Research

a month ago

AORT: Raising target price to $33.00

MT Newswires

2 months ago

Artivion Insider Sold Shares Worth $442,500, According to a Recent SEC Filing

Argus Research

2 months ago

AORT: Raising target price to $31.00

Artivion to Participate in Upcoming Investor Conferences

PR Newswire

2 months ago

Artivion to Participate in Upcoming Investor Conferences

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

PR Newswire

2 months ago

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

Returns On Capital At Artivion (NYSE:AORT) Have Stalled

Simply Wall St.

2 months ago

Returns On Capital At Artivion (NYSE:AORT) Have Stalled

Argus Research

3 months ago

AORT: Raising target price to $31.00

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

PR Newswire

3 months ago

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

Argus Research

3 months ago

AORT: Raising target price to $30.00

Artivion Reports First Quarter 2025 Financial Results

PR Newswire

3 months ago

Artivion Reports First Quarter 2025 Financial Results

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

PR Newswire

3 months ago

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Argus Research

3 months ago

AORT: What does Argus have to say about AORT?

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

PR Newswire

3 months ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Argus Research

4 months ago

AORT: Raising target price to $24.00

Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year

Simply Wall St.

4 months ago

Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year

Argus Research

4 months ago

AORT: Lowering target price to $23.00

Argus Research

4 months ago

AORT: What does Argus have to say about AORT?

Argus Research

4 months ago

AORT: Raising target price to $26.00

Do Options Traders Know Something About Artivion (AORT) Stock We Don't?

Zacks

4 months ago

Do Options Traders Know Something About Artivion (AORT) Stock We Don't?

Argus Research

5 months ago

AORT: Lowering target price to $26.00

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

PR Newswire

5 months ago

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Artivion Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

5 months ago

Artivion Full Year 2024 Earnings: EPS Misses Expectations

Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround

Zacks

5 months ago

Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround

Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts

Simply Wall St.

5 months ago

Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts

Artivion price target lowered to $32 from $34 at Needham

TipRanks

5 months ago

Artivion price target lowered to $32 from $34 at Needham

Argus Research

5 months ago

AORT: Lowering target price to $27.00

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire

5 months ago

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26?

Simply Wall St.

5 months ago

Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26?

Argus Research

6 months ago

AORT: Lowering target price to $31.00

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

PR Newswire

6 months ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Argus Research

6 months ago

AORT: What does Argus have to say about AORT?

Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)

Simply Wall St.

6 months ago

Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)

Argus Research

6 months ago

AORT: What does Argus have to say about AORT?

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

PR Newswire

6 months ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Argus Research

6 months ago

AORT: Raising target price to $33.00

Argus Research

7 months ago

AORT: What does Argus have to say about AORT?

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Simply Wall St.

7 months ago

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Argus Research

7 months ago

AORT: What does Argus have to say about AORT?

Argus Research

8 months ago

AORT: Lowering target price to $30.00

Argus Research

8 months ago

AORT: What does Argus have to say about AORT?

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

PR Newswire

8 months ago

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Argus Research

8 months ago

AORT: Rating increased to a HOLD

Returns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT)

Simply Wall St.

8 months ago

Returns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT)

Argus Research

9 months ago

AORT: What does Argus have to say about AORT?

Artivion Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Artivion Third Quarter 2024 Earnings: Beats Expectations

Artivion Reports Third Quarter 2024 Financial Results

PR Newswire

9 months ago

Artivion Reports Third Quarter 2024 Financial Results

Argus Research

9 months ago

AORT: Raising target price to $22.00

Artivion to Participate in Upcoming Investor Conferences

PR Newswire

9 months ago

Artivion to Participate in Upcoming Investor Conferences

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

PR Newswire

9 months ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

PR Newswire

10 months ago

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Argus Research

10 months ago

AORT: Lowering target price to $27.00

Those who invested in Artivion (NYSE:AORT) a year ago are up 61%

Simply Wall St.

10 months ago

Those who invested in Artivion (NYSE:AORT) a year ago are up 61%

Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)?

Simply Wall St.

a year ago

Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)?

Argus Research

a year ago

AORT: Raising target price to $30.00

Argus Research

a year ago

AORT: Raising target price to $28.00

A Look At The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)

Artivion Reports Second Quarter 2024 Financial Results

PR Newswire

a year ago

Artivion Reports Second Quarter 2024 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

PR Newswire

a year ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Argus Research

a year ago

AORT: Raising target price to $29.00

Argus Research

a year ago

AORT: Rating increased to a HOLD

Argus Research

a year ago

AORT: What does Argus have to say about AORT?

Artivion Amends Agreements with Endospan

PR Newswire

a year ago

Artivion Amends Agreements with Endospan

Artivion's (NYSE:AORT) Returns Have Hit A Wall

Simply Wall St.

a year ago

Artivion's (NYSE:AORT) Returns Have Hit A Wall

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

a year ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

a year ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

a year ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Lyft stock earns multiple upgrades after investor day

Yahoo Finance Video

a year ago

Lyft stock earns multiple upgrades after investor day

Finally, I can make my iPhone look like total crap

Engadget

a year ago

Finally, I can make my iPhone look like total crap

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors

GlobeNewswire

a year ago

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors

Stock Split Watch: 3 Growth Stocks That Could Be Next

Motley Fool

a year ago

Stock Split Watch: 3 Growth Stocks That Could Be Next

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

PR Newswire

a year ago

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen

Business Wire

a year ago

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen

Reuters

a year ago

Exclusive-Search optimization company Yext to explore a sale, sources say

Government of Canada invests in activities to address diabetes in Quebec

CNW Group

a year ago

Government of Canada invests in activities to address diabetes in Quebec

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

Zacks

a year ago

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being

Simply Wall St.

a year ago

Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being

Artivion Reports First Quarter 2024 Financial Results

PR Newswire

a year ago

Artivion Reports First Quarter 2024 Financial Results

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

PR Newswire

a year ago

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

Argus Research

a year ago

AORT: Raising target price to $22.00

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

PR Newswire

a year ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year

Simply Wall St.

a year ago

Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

PR Newswire

a year ago

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Are Medical Stocks Lagging Artivion (AORT) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Artivion (AORT) This Year?

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

PR Newswire

a year ago

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Share on Social Networks: